The metabolic trap: Candida parapsilosis inhibits Staphylococcus aureus biofilm maturation by disrupting pH homeostasis and inducing premature exodus
Open Access
- 29 July 2026
- journal article
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 75 (7) , 002186
Abstract
Introduction. Hospital-acquired infections (HAIs) frequently manifest as device-related biofilms that exhibit enhanced tolerance to conventional therapies contributing to antimicrobial resistance. Polymicrobial biofilms involving Candida and Staphylococcus species are a major cause of persistent nosocomial infections. However, while the synergism between Candida albicans and Staphylococcus aureus is well-characterized, the interactions involving non-albicans Candida remain poorly understood. Hypothesis/Gap Statement. The specific interactions between Candida parapsilosis and S. aureus were entirely unknown, although it was broadly assumed they would be synergistic in nature, mirroring known Candida–Staphylococcus models. Aim. This study investigated the interspecies dynamics between C. parapsilosis and S. aureus within a mixed biofilm context. Methodology. C. parapsilosis secretome fractions were isolated and screened against methicillin-sensitive (MSSA) and methicillin-resistant (MRSA) S. aureus strains. Their effects on biofilm formation, primary attachment, planktonic growth and eradication were evaluated under varying glucose concentrations, followed by transcriptomic analysis of treated staphylococcal cells. Results. We report the discovery of a small (S. aureus , characterized by the downregulation of the glycolytic pathway (e.g. tpiA , gapA ) and a failure to induce critical-acid-tolerance systems, including the arginine deiminase and urease operons. This metabolic reprogramming maintains a near-neutral local pH (5.8–6), which in turn provides an optimal environment for the observed upregulation of staphylococcal nuclease ( nuc ) ultimately degrading the extracellular matrix and preventing the development of a mature biofilm architecture. Conclusion. We propose that the C. parapsilosis secretome effectively tricks S. aureus into a premature exodus phase, where nuclease-mediated matrix degradation prevents the establishment of a stable biofilm architecture. These findings underscore the highly species-specific nature of fungal–bacterial interactions and identify a specific metabolic vulnerability in S. aureus that may be exploited to develop novel anti-biofilm strategies against polymicrobial communities.Keywords
Funding Information
- Dublin City University (Educational Trust)
- Wellcome Trust (215333/Z/19/Z)
This publication has 76 references indexed in Scilit:
- Aggregation and biofilm formation of mono- and co-culture Candida species and Staphylococcus aureus are affected by nutrients in growth mediaBiofouling, 2025
- Quantifying biofilm matrix components: effects of chlorhexidine and orthophthalaldehyde on Candida parapsilosis and Staphylococcus aureusBiofouling, 2025
- Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotypeNature Biotechnology, 2019
- Lactic Acid Produced by Glycolysis Contributed to Staphylococcus aureus Aggregation Induced by GlucoseCurrent Microbiology, 2019
- Emergence of non-Candida albicans species: Epidemiology, phylogeny and fluconazole susceptibility profileJournal of Medical Mycology, 2018
- Evaluation of culture conditions for mixed biofilm formation with clinically isolated non- albicans Candida species and Staphylococcus epidermidis on siliconeMicrobial Pathogenesis, 2017
- Characterization of biofilms formed by Candida parapsilosis, C. metapsilosis, and C. orthopsilosisInternational Journal of Medical Microbiology, 2010
- Polymicrobial bloodstream infections involving Candida species: analysis of patients and review of the literatureDiagnostic Microbiology and Infectious Disease, 2007
- Environmental regulation of biofilm development in methicillin-resistant and methicillin-susceptible Staphylococcus aureus clinical isolatesJournal of Hospital Infection, 2006
- Understanding biofilm resistance to antibacterial agentsNature Reviews Drug Discovery, 2003